In addition, HSC ferroptosis is also implicated in other human diseases characterized by HSC loss such as Fanconi anemia and aplastic anemia [52], highlighting a broader therapeutic potential of IGF1 in a number of BM failure syndromes. This evidence concerns the gene IGF1 and Fanconi anemia.